Connect with us
Prague Gaming & TECH Summit 2024

Fintech PR

Cristóbal Conde Appointed Chairman of FinTech and GovTech Leader Fimatix

Published

on

 

Fimatix has announced the appointment of Cristóbal Conde as Non-Executive Chairman effective from 23 March 2021. Formerly Chairman of Calastone, the major global funds network recently sold to The Carlyle Group (NASDAQ: CG), Conde brings a wealth of business, fintech and investment experience. He will work closely with the senior management team as Fimatix continues its growth and M&A drive, identifying opportunities to acquire other fintech and govtech firms.

Conde has a strong track record of accelerating the growth of fintech companies. In 1983 Conde co-founded a financial technology software business, Devon Systems, serving the derivatives markets globally. After SunGard acquired Devon Systems in 1987, Conde ran his business as a division of the parent company, growing it into one of the largest businesses at SunGard. Conde was subsequently promoted to run the entire SunGard business, which he took private in 2005 in a record-breaking $11.3bn LBO transaction. Conde stepped down from SunGard in May 2011, by which time the technology giant had revenues of $5.6bn, employed over 25,000 globally, was ranked 380th on the Fortune 500 list and was the largest privately held business software and IT services company in the world.

Conde’s appointment follows the recent appointment of Tim Howarth as Chief Executive of Fimatix. Together they will work closely with senior colleagues including Stephen O’Sullivan, with a focus on strategy and M&A; Paul James, COO; Jeremy Renwick, – Innovation; and Hugh Ivory, Business Operations and Corporate Governance who is driving the growth of the business in Ireland.

Cris Conde said, on his appointment: “I am delighted to take on the role of Chairman. Fimatix has such strong expertise in delivering innovative products and services, digital transformation, agile coaching and solving problems with innovative tech. This is an exciting time for the business and I am proud to be working with the management team as they execute the roadmap to further growth, through building strong solutions and targeted acquisitions.”

Tim Howarth, CEO of Fimatix, said: “We are honoured that Cris will be taking the role of Chairman. His insight and experience of building successful businesses will be a great asset to Fimatix as we continue to target organic growth and acquisitions. As a company we want to provide technological innovation, and solutions that are relevant to client demands, for the good of society, the economy and people around the world. Chris shares our values and ambition for Fimatix and we are pleased to welcome him to the board.”

Conde joins the company a year since the merger of Fimatix and Agilesphere. With a team of over 150 staff, partners and associates, and offices in London and Newcastle, the combined company has a good foundation from which it offers services at scale. Since the merger, Fimatix has launched ‘Shield’, an independent COVID-19 track and trace system used in schools and workplaces, ‘Talent as a Service’, supporting HR teams and specialist advice services on IR35 and recruitment, Privacy4cars in the UK and continues to provide long term transformation support to the UK Government as a top 20 Digital Outcomes and Specialist supplier.

Fimatix’s purpose is to enhance the productivity of business and governments to the benefit of economies, communities and people around the world. The business has a track record of supporting major banks and e-money fintech challengers within the financial services sector and businesses in the leisure industry. The team enables digital transformation in UK Government including the Department of Health and Social Care, the Ministry of Justice, the Department for Work and Pensions and the Ministry of Housing, Communities and Local Government.

Fintech PR

Telkomsel and Huawei Inaugurate Indonesia’s First 5G Smart Warehouse and 5G Innovation Center

Published

on

telkomsel-and-huawei-inaugurate-indonesia’s-first-5g-smart-warehouse-and-5g-innovation-center

JAKARTA, Indonesia, March 19, 2024 /PRNewswire/ — Leading telecommunications provider Telkomsel and global ICT solutions provider Huawei have inaugurated Indonesia’s first 5G Smart Warehouse and 5G Innovation Center in Bekasi Regency, West Java. This landmark facility showcases the potential of 5G technology to transform warehouse management, boosting operational efficiency and creating new opportunities for the logistics industry to support the digital economy leapfrog towards the Golden Indonesia Vision 2045.

The inauguration ceremony was officiated by Mr. Long, CEO of Huawei Indonesia, and attended by dignitaries including Dr. Ir. Ismail MT, Director General of Resources Management and Equipment of Posts and Informatics, Ministry of Communication and Informatics; Indra Mardiatna, Telkomsel Director of Network; Derrick Heng, Telkomsel Marketing Director; Mahendra Rianto, Chairman of the Indonesian Logistics Association; and representatives from Bandung Institute of Technology, Telkom University, and other representatives from industry partners.

Director General Dr. Ir. Ismail MT emphasized, “Huawei’s 5G Smart Warehouse stands as both a wake-up call and a quintessential model for the ecosystem, demonstrating the immediate and seamless integration of 5G technology into digitalization efforts. This integration evidently yields innovative solutions that extend benefits beyond the logistics sector to a multitude of industries. Such advancements are attainable solely through the concerted efforts of all stakeholders, united in the pursuit of accelerating the nation’s digital transformation.”

Mr. Long, CEO of Huawei Indonesia, highlighted Huawei’s commitment to supporting the government and industry players to unlock Indonesia’s digital opportunities. “At last year’s Solo 5G summit, together with industry partners, we pledged to boost the 5G ecosystem. The 5G Smart Warehouse is a testament to the value that 5G technology can bring to traditional industries in Indonesia,” he stated.

Indra Mardiatna, Telkomsel Director of Network remarked, “Aligned with Indonesia’s vision of pioneering innovations that propel the nation’s advancement, Telkomsel remains steadfast in its commitment to deliver superior connectivity, pioneering solutions, and inventive services designed to foster empowerment and catalyze expansive opportunities for entrepreneurial growth within the country. We are optimistic that the deployment of the 5G Smart Warehouse alongside the 5G Innovation Center’s conceptual solutions will inaugurate a transformative era for professionals within the logistics sector, particularly by enhancing managerial competencies and amplifying the operational efficacy of warehousing systems. With the unwavering support of the government, courtesy of the Ministry of Communication and Information, and through synergistic partnerships with stakeholders including Huawei, industry associations, and the academic community, Telkomsel pledges to persist in championing the rapid evolution of Indonesia’s digital commerce and economic landscape, with a focus on inclusive and sustainable progress”

The digital economy, which is expected to be a major catalyst for Indonesia’s economy in the future, requires the backing of an efficient and effective logistics industry. Based on data from the Ministry of National Development Planning/Bappenas, Indonesia’s logistics costs have decreased from 23.5% to 14.29% of gross domestic product by 2023.

Benefits of the 5G Smart Warehouse 

Indonesia's first 5G Smart Warehouse

The 5G Smart Warehouse leverages advanced technologies like IoT and big data analytics to streamline operations, enhance safety and security, increase efficiency, and reduce energy consumptions and lower potential unexpected losses.

Warehouse managers can use digital twins and real-time data analysis to optimize inventory management and prevent stockouts.

The 5G network also facilitates swift and accurate communication between staff and autonomous guided vehicles (AGVs), ensuring efficient goods movement. Additionally, intelligent security systems powered by video and infrared sensors ensure warehouse safety.

Huawei’s 5G BTS technology powering the warehouse features an energy consumption of just 5 watts, equivalent to a single energy-saving light bulb, making it a sustainable solution for the future.

Photo – https://mma.prnewswire.com/media/2365771/Telkomsel_Huawei_inaugurating_Indonesia_s_5G_Smart_Warehouse_togther_partners.jpg

Photo – https://mma.prnewswire.com/media/2365772/Indonesia_s_5G_Smart_Warehouse.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/telkomsel-and-huawei-inaugurate-indonesias-first-5g-smart-warehouse-and-5g-innovation-center-302092422.html

Continue Reading

Fintech PR

Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Published

on

cognizant-to-apply-generative-ai-to-enhance-drug-discovery-for-pharmaceutical-clients-with-nvidia-bionemo

Cognizant’s AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors

TEANECK, N.J., March 19, 2024 /PRNewswire/ — Cognizant (NASDAQ: CTSH) is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex challenges of drug discovery in the life sciences industry, such as improving productivity in the development process and increasing the speed at which new, life-saving treatments can be brought to market.

Traditional drug discovery methodologies are process intensive and require the analysis of vast repositories of scientific literature and clinical data in order to reveal relevant insights. Moreover, traditional methods are burdened with high costs and long development lifecycles with a high rate of failure. By leveraging gen AI technologies, clinical researchers can rapidly sift through extensive datasets, more accurately predict interactions between drug compounds and create new, viable drug development pathways. 

“More than any other technological breakthrough in recent decades, generative AI has the potential to revolutionize the way new drugs are researched, developed and brought to market, making the creation of lifesaving discoveries faster, smarter and more accessible to all,” said Anna Elango, EVP, Cognizant’s Core Technologies & Insights. “By collaborating with NVIDIA, Cognizant can open the path to realizing this vision safely, responsibly and cost-effectively for our life sciences clients.”

By leveraging its deep life sciences and AI domain expertise and NVIDIA’s pretrained, industry-specific generative AI models offered as part of BioNeMo, Cognizant aims to give clients access to a suite of model-making services, including pretrained models, cutting-edge frameworks, and APIs, that offers clients the quickest path to train and customize enterprise models using their proprietary data. The offering is intended to enable this with reduced manual intervention for data analysis, and without the need to write elaborate code and build or maintain infrastructure.

“Generative AI will drive the next wave of enterprise productivity gains across industries, enabled by the NVIDIA AI Enterprise software platform,” said Alvin DaCosta, VP, Global Consulting Partner Organization, NVIDIA. “Using NVIDIA BioNeMo, Cognizant will help provide its life sciences clients with advanced, secure and reliable AI services to drive improved outcomes with custom drug discovery applications.”

Cognizant collaborates with leading global firms in pharmaceuticals, biotech and medical devices, covering the entire life sciences value chain from R&D to digital health. This work contributes to the industry’s ability to enhance science, improve patient outcomes, and increase business value, by enabling a patient-centric approach and better interactions with healthcare professionals. Cognizant’s life sciences offerings support more than 120 global manufacturing lines and more than 18 million patients with medical device company products. 

Cognizant intends to pursue additional applications by collaborating with NVIDIA in areas such as manufacturing and automotive engineering, where gen AI has the potential to enhance productivity, optimize costs and bring innovation to market more quickly. Cognizant intends to establish an NVIDIA AI Center of Excellence this year to further innovate with NVIDIA technologies, including the NVIDIA Metropolis, NVIDIA Omniverse and NVIDIA AI Enterprise platforms, for the benefit of clients across industries around the world.

About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we’re improving everyday life. See how at www.cognizant.com or @cognizant.

For more information, contact:

U.S.

Name Ben Gorelick

Email 
[email protected] 

Europe / APAC

Name Christina Schneider

Email
[email protected] 

India

Name Rashmi Vasisht

Email
[email protected] 

Logo – https://mma.prnewswire.com/media/1794711/Cognizant_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/cognizant-to-apply-generative-ai-to-enhance-drug-discovery-for-pharmaceutical-clients-with-nvidia-bionemo-302092233.html

Continue Reading

Fintech PR

ICP DAS-BMP Secures Pivotal TPU Deals with Medical Materials Leaders in U.S. and Japan, Boosts Product Reliability

Published

on

icp-das-bmp-secures-pivotal-tpu-deals-with-medical-materials-leaders-in-us.-and-japan,-boosts-product-reliability

HSINCHU, March 19, 2024 /PRNewswire/ — ICP DAS-BMP dazzled at the prestigious MD&M West Show, where its high-quality medical-grade thermoplastic polyurethane (TPU) garnered orders from top manufacturers in U.S. and Japan. Concurrently, part of the company’s TPU products passed the ISO10993-6 test for local effects after 90-day implantation, positioning them as ideal materials for producing indwelling medical devices intended for use over 30 days.

ICP DAS-BMP, Asia’s first medical-grade TPU supplier, produces three main series of products: Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series). The company is set to launch a new Durathane™ (ARC series), known for its exceptional biostability. All the TPU series are available in different hardness levels, colors, and concentrations of radiopaque fillers (Tungsten/Barium Sulfate). These materials are widely utilized in manufacturing cardiovascular, urological, and gastrointestinal devices, as well as medical and electromedical consumables.

ICP DAS-BMP’s Arothane™ ARP-B20 (20% Barium Sulfate) and Durathane™ ALC-B40 (40% Barium Sulfate) passed the ISO10993-6 90-day implantation test. This qualifies them for long-term invasive or implantable medical applications such as peripherally inserted central catheters (PICC) and port-a-cath. The company plans to conduct long-term implantation tests for other specifications of TPU products based on customer demand, while advancing research and development to uphold TPU product quality.

ICP DAS-BMP Medical Grade TPU Biocompatibility and Other Testing

Medical-grade TPU differs from other plastics by emitting minimal VOCs during manufacturing and having low wastewater discharge, making it extremely environmentally friendly. It contains no plasticizers or heavy metals, ensuring excellent biocompatibility and blood compatibility, and enhancing ESG sustainability. ICP DAS-BMP aims to offer safer, stable, and eco-friendly medical-grade TPU, collaborating with global medical device manufacturers to create long-term benefits and value.

Meet the company’s experts at:

CMEF (ICMD) 2024 (April 11-14) 
Booth Hall 8.1, M44, M46
NECC (Shanghai), China

Medtec Japan 2024 (April 17-19) 
Booth 2022
Tokyo Big Sight East 2~3 Hall, Japan

About ICP DAS-BMP

ICP DAS-BMP, a Taiwan-based TPU manufacturer and supplier certified with ISO 13485, operates specialized laboratories dedicated to quality management. Drawing upon three decades of industrial automation expertise from its parent company ICP DAS, ICP DAS-BMP has implemented smart factory practices to enhance product quality and expedite delivery times. Additionally, the company provides responsive after-sales support and offers flexible solutions for small order quantities.

For more information, please visit: https://bmp.icpdas.com/

For TPU products and inquiries, contact: [email protected]

ICP DAS – BMP

Photo – https://mma.prnewswire.com/media/2364434/ICP_DAS_BMP_Secures_Pivotal_TPU_Deals_with_Medical_Materials_Leaders_in_U_S__and_Japan__Boosts_Produ.jpg
Photo – https://mma.prnewswire.com/media/2364438/ICP_DAS_BMP_Medical_Grade_TPU_Biocompatibility_and_Other_Testing.jpg
Logo – https://mma.prnewswire.com/media/2261949/ICP_DAS___Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/icp-das-bmp-secures-pivotal-tpu-deals-with-medical-materials-leaders-in-us-and-japan-boosts-product-reliability-302091445.html

Continue Reading

Trending